nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—TOP2A—polycystic ovary syndrome	0.406	0.651	CbGaD
Daunorubicin—CYP1A1—polycystic ovary syndrome	0.217	0.349	CbGaD
Daunorubicin—SLC22A2—Metformin—polycystic ovary syndrome	0.0644	1	CbGbCtD
Daunorubicin—NR5A1—corpus luteum—polycystic ovary syndrome	0.0277	0.212	CbGeAlD
Daunorubicin—NR5A1—ovarian follicle—polycystic ovary syndrome	0.0217	0.166	CbGeAlD
Daunorubicin—Valrubicin—TOP2A—polycystic ovary syndrome	0.00274	0.365	CrCbGaD
Daunorubicin—NR5A1—adrenal cortex—polycystic ovary syndrome	0.0024	0.0184	CbGeAlD
Daunorubicin—CYP1A2—urine—polycystic ovary syndrome	0.00204	0.0156	CbGeAlD
Daunorubicin—NR5A1—pituitary gland—polycystic ovary syndrome	0.00194	0.0149	CbGeAlD
Daunorubicin—Nail disorder—Metformin—polycystic ovary syndrome	0.00194	0.0661	CcSEcCtD
Daunorubicin—TOP2B—embryo—polycystic ovary syndrome	0.00187	0.0143	CbGeAlD
Daunorubicin—NR5A1—adrenal gland—polycystic ovary syndrome	0.00173	0.0133	CbGeAlD
Daunorubicin—NR5A1—female gonad—polycystic ovary syndrome	0.00162	0.0124	CbGeAlD
Daunorubicin—YWHAG—adrenal cortex—polycystic ovary syndrome	0.00159	0.0122	CbGeAlD
Daunorubicin—Idarubicin—TOP2A—polycystic ovary syndrome	0.00157	0.21	CrCbGaD
Daunorubicin—Rigors—Metformin—polycystic ovary syndrome	0.00154	0.0525	CcSEcCtD
Daunorubicin—TOP2B—adrenal cortex—polycystic ovary syndrome	0.00153	0.0117	CbGeAlD
Daunorubicin—NR5A1—endocrine gland—polycystic ovary syndrome	0.0015	0.0115	CbGeAlD
Daunorubicin—CYP3A4—urine—polycystic ovary syndrome	0.00147	0.0113	CbGeAlD
Daunorubicin—Chest discomfort—Metformin—polycystic ovary syndrome	0.00142	0.0484	CcSEcCtD
Daunorubicin—YWHAG—endometrium—polycystic ovary syndrome	0.00142	0.0109	CbGeAlD
Daunorubicin—XDH—endometrium—polycystic ovary syndrome	0.00138	0.0106	CbGeAlD
Daunorubicin—TOP2B—endometrium—polycystic ovary syndrome	0.00137	0.0105	CbGeAlD
Daunorubicin—ABCC6—adipose tissue—polycystic ovary syndrome	0.00136	0.0104	CbGeAlD
Daunorubicin—YWHAG—uterus—polycystic ovary syndrome	0.00131	0.01	CbGeAlD
Daunorubicin—Doxorubicin—AKR1C3—polycystic ovary syndrome	0.00131	0.174	CrCbGaD
Daunorubicin—YWHAG—pituitary gland—polycystic ovary syndrome	0.00128	0.00983	CbGeAlD
Daunorubicin—YWHAG—adipose tissue—polycystic ovary syndrome	0.00128	0.00979	CbGeAlD
Daunorubicin—TOP2B—uterus—polycystic ovary syndrome	0.00126	0.00964	CbGeAlD
Daunorubicin—TOP2B—pituitary gland—polycystic ovary syndrome	0.00124	0.00947	CbGeAlD
Daunorubicin—TOP2B—adipose tissue—polycystic ovary syndrome	0.00123	0.00943	CbGeAlD
Daunorubicin—POR—adrenal cortex—polycystic ovary syndrome	0.00121	0.00925	CbGeAlD
Daunorubicin—Epirubicin—TOP2A—polycystic ovary syndrome	0.00119	0.159	CrCbGaD
Daunorubicin—Neuropathy—Metformin—polycystic ovary syndrome	0.00118	0.0402	CcSEcCtD
Daunorubicin—YWHAG—adrenal gland—polycystic ovary syndrome	0.00115	0.00878	CbGeAlD
Daunorubicin—TOP2B—adrenal gland—polycystic ovary syndrome	0.0011	0.00846	CbGeAlD
Daunorubicin—POR—endometrium—polycystic ovary syndrome	0.00108	0.00826	CbGeAlD
Daunorubicin—Ear pain—Metformin—polycystic ovary syndrome	0.00107	0.0365	CcSEcCtD
Daunorubicin—YWHAG—female gonad—polycystic ovary syndrome	0.00107	0.00819	CbGeAlD
Daunorubicin—YWHAG—vagina—polycystic ovary syndrome	0.00106	0.00814	CbGeAlD
Daunorubicin—ABCC6—endocrine gland—polycystic ovary syndrome	0.00105	0.00809	CbGeAlD
Daunorubicin—XDH—vagina—polycystic ovary syndrome	0.00104	0.00793	CbGeAlD
Daunorubicin—TOP2B—female gonad—polycystic ovary syndrome	0.00103	0.00789	CbGeAlD
Daunorubicin—TOP2B—vagina—polycystic ovary syndrome	0.00102	0.00784	CbGeAlD
Daunorubicin—TOP2A—endometrium—polycystic ovary syndrome	0.001	0.0077	CbGeAlD
Daunorubicin—YWHAG—endocrine gland—polycystic ovary syndrome	0.000993	0.00761	CbGeAlD
Daunorubicin—POR—pituitary gland—polycystic ovary syndrome	0.000975	0.00747	CbGeAlD
Daunorubicin—POR—adipose tissue—polycystic ovary syndrome	0.000971	0.00744	CbGeAlD
Daunorubicin—XDH—endocrine gland—polycystic ovary syndrome	0.000969	0.00742	CbGeAlD
Daunorubicin—Renal impairment—Metformin—polycystic ovary syndrome	0.000958	0.0327	CcSEcCtD
Daunorubicin—ABCC10—adrenal cortex—polycystic ovary syndrome	0.000957	0.00734	CbGeAlD
Daunorubicin—TOP2B—endocrine gland—polycystic ovary syndrome	0.000957	0.00734	CbGeAlD
Daunorubicin—ABCB11—endocrine gland—polycystic ovary syndrome	0.000946	0.00725	CbGeAlD
Daunorubicin—TOP2A—uterus—polycystic ovary syndrome	0.000925	0.00709	CbGeAlD
Daunorubicin—TOP2A—adipose tissue—polycystic ovary syndrome	0.000905	0.00694	CbGeAlD
Daunorubicin—POR—adrenal gland—polycystic ovary syndrome	0.000871	0.00667	CbGeAlD
Daunorubicin—ABCC10—endometrium—polycystic ovary syndrome	0.000855	0.00655	CbGeAlD
Daunorubicin—Dehydration—Metformin—polycystic ovary syndrome	0.000848	0.0289	CcSEcCtD
Daunorubicin—POR—female gonad—polycystic ovary syndrome	0.000812	0.00622	CbGeAlD
Daunorubicin—TOP2A—adrenal gland—polycystic ovary syndrome	0.000812	0.00622	CbGeAlD
Daunorubicin—POR—vagina—polycystic ovary syndrome	0.000807	0.00619	CbGeAlD
Daunorubicin—ABCC10—uterus—polycystic ovary syndrome	0.000788	0.00604	CbGeAlD
Daunorubicin—ABCC10—pituitary gland—polycystic ovary syndrome	0.000774	0.00593	CbGeAlD
Daunorubicin—ABCC10—adipose tissue—polycystic ovary syndrome	0.00077	0.0059	CbGeAlD
Daunorubicin—Sweating increased—Metformin—polycystic ovary syndrome	0.000767	0.0262	CcSEcCtD
Daunorubicin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000767	0.0262	CcSEcCtD
Daunorubicin—TOP2A—female gonad—polycystic ovary syndrome	0.000757	0.0058	CbGeAlD
Daunorubicin—POR—endocrine gland—polycystic ovary syndrome	0.000755	0.00579	CbGeAlD
Daunorubicin—TOP2A—vagina—polycystic ovary syndrome	0.000752	0.00577	CbGeAlD
Daunorubicin—Neutropenia—Metformin—polycystic ovary syndrome	0.000737	0.0251	CcSEcCtD
Daunorubicin—ABCC10—adrenal gland—polycystic ovary syndrome	0.000691	0.0053	CbGeAlD
Daunorubicin—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000688	0.0235	CcSEcCtD
Daunorubicin—Doxorubicin—TOP2A—polycystic ovary syndrome	0.000684	0.0913	CrCbGaD
Daunorubicin—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000677	0.00519	CbGeAlD
Daunorubicin—ABCC10—female gonad—polycystic ovary syndrome	0.000644	0.00494	CbGeAlD
Daunorubicin—ABCC10—vagina—polycystic ovary syndrome	0.00064	0.00491	CbGeAlD
Daunorubicin—Rhinitis—Metformin—polycystic ovary syndrome	0.000632	0.0216	CcSEcCtD
Daunorubicin—CYP1B1—uterus—polycystic ovary syndrome	0.000619	0.00475	CbGeAlD
Daunorubicin—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000608	0.00466	CbGeAlD
Daunorubicin—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000606	0.00464	CbGeAlD
Daunorubicin—ABCC1—endometrium—polycystic ovary syndrome	0.000605	0.00463	CbGeAlD
Daunorubicin—ABCC10—endocrine gland—polycystic ovary syndrome	0.000599	0.00459	CbGeAlD
Daunorubicin—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000585	0.02	CcSEcCtD
Daunorubicin—Flushing—Metformin—polycystic ovary syndrome	0.000585	0.02	CcSEcCtD
Daunorubicin—Chills—Metformin—polycystic ovary syndrome	0.000566	0.0193	CcSEcCtD
Daunorubicin—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000561	0.0043	CbGeAlD
Daunorubicin—ABCC1—uterus—polycystic ovary syndrome	0.000557	0.00427	CbGeAlD
Daunorubicin—ABCC2—adrenal gland—polycystic ovary syndrome	0.000555	0.00425	CbGeAlD
Daunorubicin—Erythema—Metformin—polycystic ovary syndrome	0.000549	0.0187	CcSEcCtD
Daunorubicin—ABCC1—pituitary gland—polycystic ovary syndrome	0.000547	0.00419	CbGeAlD
Daunorubicin—ABCC1—adipose tissue—polycystic ovary syndrome	0.000545	0.00418	CbGeAlD
Daunorubicin—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000543	0.00416	CbGeAlD
Daunorubicin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000537	0.0184	CcSEcCtD
Daunorubicin—Tremor—Metformin—polycystic ovary syndrome	0.000514	0.0176	CcSEcCtD
Daunorubicin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000509	0.0174	CcSEcCtD
Daunorubicin—CYP1B1—female gonad—polycystic ovary syndrome	0.000507	0.00388	CbGeAlD
Daunorubicin—ABCG2—endometrium—polycystic ovary syndrome	0.000501	0.00384	CbGeAlD
Daunorubicin—Malaise—Metformin—polycystic ovary syndrome	0.000495	0.0169	CcSEcCtD
Daunorubicin—Syncope—Metformin—polycystic ovary syndrome	0.000492	0.0168	CcSEcCtD
Daunorubicin—ABCC1—adrenal gland—polycystic ovary syndrome	0.000489	0.00375	CbGeAlD
Daunorubicin—Palpitations—Metformin—polycystic ovary syndrome	0.000485	0.0166	CcSEcCtD
Daunorubicin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000482	0.0165	CcSEcCtD
Daunorubicin—ABCC2—endocrine gland—polycystic ovary syndrome	0.000481	0.00369	CbGeAlD
Daunorubicin—Hypertension—Metformin—polycystic ovary syndrome	0.000474	0.0162	CcSEcCtD
Daunorubicin—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000471	0.00361	CbGeAlD
Daunorubicin—Myalgia—Metformin—polycystic ovary syndrome	0.000467	0.016	CcSEcCtD
Daunorubicin—Chest pain—Metformin—polycystic ovary syndrome	0.000467	0.016	CcSEcCtD
Daunorubicin—Discomfort—Metformin—polycystic ovary syndrome	0.000462	0.0158	CcSEcCtD
Daunorubicin—ABCG2—uterus—polycystic ovary syndrome	0.000461	0.00353	CbGeAlD
Daunorubicin—ABCC1—female gonad—polycystic ovary syndrome	0.000456	0.00349	CbGeAlD
Daunorubicin—ABCC1—vagina—polycystic ovary syndrome	0.000453	0.00347	CbGeAlD
Daunorubicin—ABCG2—pituitary gland—polycystic ovary syndrome	0.000453	0.00347	CbGeAlD
Daunorubicin—ABCG2—adipose tissue—polycystic ovary syndrome	0.000451	0.00346	CbGeAlD
Daunorubicin—Oedema—Metformin—polycystic ovary syndrome	0.000448	0.0153	CcSEcCtD
Daunorubicin—Infection—Metformin—polycystic ovary syndrome	0.000445	0.0152	CcSEcCtD
Daunorubicin—Shock—Metformin—polycystic ovary syndrome	0.000441	0.015	CcSEcCtD
Daunorubicin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000439	0.015	CcSEcCtD
Daunorubicin—CYP1A1—uterus—polycystic ovary syndrome	0.000438	0.00336	CbGeAlD
Daunorubicin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000433	0.0148	CcSEcCtD
Daunorubicin—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000428	0.00328	CbGeAlD
Daunorubicin—Anorexia—Metformin—polycystic ovary syndrome	0.000427	0.0146	CcSEcCtD
Daunorubicin—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000419	0.00321	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000408	0.0139	CcSEcCtD
Daunorubicin—ABCG2—adrenal gland—polycystic ovary syndrome	0.000405	0.0031	CbGeAlD
Daunorubicin—Dyspnoea—Metformin—polycystic ovary syndrome	0.000399	0.0136	CcSEcCtD
Daunorubicin—Somnolence—Metformin—polycystic ovary syndrome	0.000398	0.0136	CcSEcCtD
Daunorubicin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000389	0.0133	CcSEcCtD
Daunorubicin—Fatigue—Metformin—polycystic ovary syndrome	0.000386	0.0132	CcSEcCtD
Daunorubicin—Constipation—Metformin—polycystic ovary syndrome	0.000383	0.0131	CcSEcCtD
Daunorubicin—ABCG2—female gonad—polycystic ovary syndrome	0.000377	0.00289	CbGeAlD
Daunorubicin—ABCG2—vagina—polycystic ovary syndrome	0.000375	0.00287	CbGeAlD
Daunorubicin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000369	0.0126	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000366	0.0125	CcSEcCtD
Daunorubicin—CYP1A1—female gonad—polycystic ovary syndrome	0.000358	0.00274	CbGeAlD
Daunorubicin—CYP1A1—vagina—polycystic ovary syndrome	0.000356	0.00273	CbGeAlD
Daunorubicin—Urticaria—Metformin—polycystic ovary syndrome	0.000356	0.0122	CcSEcCtD
Daunorubicin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000354	0.0121	CcSEcCtD
Daunorubicin—CYP3A5—female gonad—polycystic ovary syndrome	0.00035	0.00268	CbGeAlD
Daunorubicin—CYP3A5—vagina—polycystic ovary syndrome	0.000348	0.00267	CbGeAlD
Daunorubicin—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000338	0.00259	CbGeAlD
Daunorubicin—ABCB1—embryo—polycystic ovary syndrome	0.000337	0.00258	CbGeAlD
Daunorubicin—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000333	0.00255	CbGeAlD
Daunorubicin—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000326	0.0025	CbGeAlD
Daunorubicin—Asthenia—Metformin—polycystic ovary syndrome	0.000321	0.011	CcSEcCtD
Daunorubicin—Pruritus—Metformin—polycystic ovary syndrome	0.000317	0.0108	CcSEcCtD
Daunorubicin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000306	0.0105	CcSEcCtD
Daunorubicin—Dizziness—Metformin—polycystic ovary syndrome	0.000296	0.0101	CcSEcCtD
Daunorubicin—Vomiting—Metformin—polycystic ovary syndrome	0.000285	0.00972	CcSEcCtD
Daunorubicin—Rash—Metformin—polycystic ovary syndrome	0.000282	0.00964	CcSEcCtD
Daunorubicin—Dermatitis—Metformin—polycystic ovary syndrome	0.000282	0.00963	CcSEcCtD
Daunorubicin—Headache—Metformin—polycystic ovary syndrome	0.000281	0.00958	CcSEcCtD
Daunorubicin—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000276	0.00212	CbGeAlD
Daunorubicin—Nausea—Metformin—polycystic ovary syndrome	0.000266	0.00908	CcSEcCtD
Daunorubicin—ABCB1—endometrium—polycystic ovary syndrome	0.000247	0.00189	CbGeAlD
Daunorubicin—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000244	0.00187	CbGeAlD
Daunorubicin—ABCB1—uterus—polycystic ovary syndrome	0.000227	0.00174	CbGeAlD
Daunorubicin—ABCB1—pituitary gland—polycystic ovary syndrome	0.000223	0.00171	CbGeAlD
Daunorubicin—ABCB1—adipose tissue—polycystic ovary syndrome	0.000222	0.0017	CbGeAlD
Daunorubicin—ABCB1—adrenal gland—polycystic ovary syndrome	0.0002	0.00153	CbGeAlD
Daunorubicin—ABCB1—female gonad—polycystic ovary syndrome	0.000186	0.00143	CbGeAlD
Daunorubicin—ABCB1—vagina—polycystic ovary syndrome	0.000185	0.00142	CbGeAlD
Daunorubicin—ABCB1—endocrine gland—polycystic ovary syndrome	0.000173	0.00133	CbGeAlD
Daunorubicin—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	1.78e-05	0.000122	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	1.78e-05	0.000122	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	1.77e-05	0.000122	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	1.77e-05	0.000122	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	1.77e-05	0.000122	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	1.76e-05	0.000121	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC2A4—polycystic ovary syndrome	1.76e-05	0.000121	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—YAP1—polycystic ovary syndrome	1.72e-05	0.000118	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.72e-05	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	1.71e-05	0.000118	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.7e-05	0.000117	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.69e-05	0.000117	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	1.69e-05	0.000116	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—MTHFR—polycystic ovary syndrome	1.69e-05	0.000116	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	1.68e-05	0.000116	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	1.68e-05	0.000115	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.68e-05	0.000115	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP19A1—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NAMPT—polycystic ovary syndrome	1.66e-05	0.000114	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.65e-05	0.000113	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP11A1—polycystic ovary syndrome	1.63e-05	0.000112	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.63e-05	0.000112	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	1.63e-05	0.000112	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.62e-05	0.000112	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—RRM2—polycystic ovary syndrome	1.61e-05	0.000111	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	1.61e-05	0.00011	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.61e-05	0.00011	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	1.6e-05	0.00011	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	1.59e-05	0.000109	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.58e-05	0.000109	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	1.58e-05	0.000109	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	1.57e-05	0.000108	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	1.57e-05	0.000108	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—YAP1—polycystic ovary syndrome	1.55e-05	0.000107	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—AKR1C3—polycystic ovary syndrome	1.54e-05	0.000106	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP17A1—polycystic ovary syndrome	1.52e-05	0.000105	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.52e-05	0.000104	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	1.51e-05	0.000104	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.51e-05	0.000104	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—PRL—polycystic ovary syndrome	1.51e-05	0.000104	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	1.51e-05	0.000104	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	1.5e-05	0.000103	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NAMPT—polycystic ovary syndrome	1.49e-05	0.000102	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	1.49e-05	0.000102	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	1.49e-05	0.000102	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—GNAS—polycystic ovary syndrome	1.48e-05	0.000102	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.47e-05	0.000101	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.47e-05	0.000101	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.44e-05	9.91e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	1.43e-05	9.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	1.42e-05	9.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	1.42e-05	9.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.41e-05	9.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.41e-05	9.69e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—NCOR1—polycystic ovary syndrome	1.41e-05	9.68e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	1.4e-05	9.66e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.39e-05	9.56e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	1.38e-05	9.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.38e-05	9.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.38e-05	9.5e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	1.38e-05	9.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.37e-05	9.41e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—PPARG—polycystic ovary syndrome	1.37e-05	9.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.36e-05	9.36e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TH—polycystic ovary syndrome	1.36e-05	9.35e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	1.35e-05	9.28e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—POMC—polycystic ovary syndrome	1.35e-05	9.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.34e-05	9.24e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.34e-05	9.24e-05	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—INS—polycystic ovary syndrome	1.34e-05	9.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.34e-05	9.21e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CYP1A1—polycystic ovary syndrome	1.33e-05	9.17e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	9.09e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TH—polycystic ovary syndrome	1.31e-05	9.04e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	1.31e-05	8.99e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	1.3e-05	8.97e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.28e-05	8.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.28e-05	8.81e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	1.28e-05	8.8e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.28e-05	8.77e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NCOR1—polycystic ovary syndrome	1.26e-05	8.68e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—MTHFR—polycystic ovary syndrome	1.24e-05	8.55e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	1.24e-05	8.55e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NRG1—polycystic ovary syndrome	1.24e-05	8.52e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.23e-05	8.49e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	1.2e-05	8.27e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	1.2e-05	8.27e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.2e-05	8.26e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.2e-05	8.24e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.2e-05	8.23e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.19e-05	8.16e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TH—polycystic ovary syndrome	1.18e-05	8.14e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.17e-05	8.01e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.16e-05	8e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.15e-05	7.92e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.14e-05	7.86e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.14e-05	7.81e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.13e-05	7.75e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.12e-05	7.73e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.12e-05	7.72e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTHFR—polycystic ovary syndrome	1.12e-05	7.67e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	7.63e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	1.1e-05	7.57e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.09e-05	7.52e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.09e-05	7.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.09e-05	7.51e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.08e-05	7.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.08e-05	7.42e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	1.07e-05	7.38e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.07e-05	7.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.07e-05	7.33e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IRS2—polycystic ovary syndrome	1.06e-05	7.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	1.06e-05	7.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.06e-05	7.29e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	1.06e-05	7.27e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.04e-05	7.17e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	1.02e-05	7.03e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	1.02e-05	7.01e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.02e-05	7e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.01e-05	6.97e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—PPARG—polycystic ovary syndrome	1.01e-05	6.94e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.01e-05	6.92e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.01e-05	6.92e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1e-05	6.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1e-05	6.87e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—POMC—polycystic ovary syndrome	9.95e-06	6.84e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	9.91e-06	6.81e-05	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—INS—polycystic ovary syndrome	9.89e-06	6.8e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	9.86e-06	6.78e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	9.77e-06	6.72e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	9.69e-06	6.67e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	9.67e-06	6.65e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	9.56e-06	6.57e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	9.51e-06	6.54e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	9.36e-06	6.44e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	9.34e-06	6.43e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	9.3e-06	6.4e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IRS1—polycystic ovary syndrome	9.27e-06	6.37e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	9.21e-06	6.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.16e-06	6.3e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.12e-06	6.27e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	9.08e-06	6.24e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	9.04e-06	6.21e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.02e-06	6.2e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—INS—polycystic ovary syndrome	8.87e-06	6.1e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	8.82e-06	6.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	8.79e-06	6.05e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	8.73e-06	6e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.68e-06	5.97e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—AKT2—polycystic ovary syndrome	8.58e-06	5.9e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TH—polycystic ovary syndrome	8.57e-06	5.89e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.55e-06	5.88e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	8.47e-06	5.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	8.34e-06	5.73e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.32e-06	5.72e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.28e-06	5.69e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	8.22e-06	5.65e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	8.15e-06	5.6e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	8.14e-06	5.6e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	8.14e-06	5.6e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.13e-06	5.59e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TH—polycystic ovary syndrome	8.1e-06	5.57e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	8.04e-06	5.53e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	7.88e-06	5.42e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	7.87e-06	5.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	7.84e-06	5.39e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	7.59e-06	5.22e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	7.58e-06	5.21e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	7.48e-06	5.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—POMC—polycystic ovary syndrome	7.47e-06	5.14e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—INS—polycystic ovary syndrome	7.43e-06	5.11e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.41e-06	5.09e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.38e-06	5.07e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	7.33e-06	5.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.25e-06	4.98e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	7.23e-06	4.97e-05	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—INS—polycystic ovary syndrome	7.19e-06	4.94e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.04e-06	4.84e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	7.02e-06	4.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	7e-06	4.81e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	6.77e-06	4.65e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	6.67e-06	4.58e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	6.67e-06	4.58e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	6.61e-06	4.55e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	6.6e-06	4.54e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—POMC—polycystic ovary syndrome	6.58e-06	4.52e-05	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—INS—polycystic ovary syndrome	6.54e-06	4.5e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	6.51e-06	4.47e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.5e-06	4.47e-05	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—INS—polycystic ovary syndrome	6.47e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TH—polycystic ovary syndrome	6.47e-06	4.45e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.46e-06	4.44e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.42e-06	4.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.42e-06	4.41e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.37e-06	4.38e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	6.32e-06	4.35e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	6.3e-06	4.33e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	6.29e-06	4.33e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.27e-06	4.31e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.08e-06	4.18e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.06e-06	4.17e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	5.97e-06	4.1e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	5.92e-06	4.07e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	5.89e-06	4.05e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.59e-06	3.85e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	5.57e-06	3.83e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.42e-06	3.72e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.28e-06	3.63e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.22e-06	3.59e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.16e-06	3.55e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.03e-06	3.46e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.02e-06	3.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.02e-06	3.45e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.95e-06	3.41e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	4.78e-06	3.28e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	4.77e-06	3.28e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.72e-06	3.25e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	4.71e-06	3.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—INS—polycystic ovary syndrome	4.69e-06	3.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.68e-06	3.22e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.61e-06	3.17e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	4.51e-06	3.1e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	4.45e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.45e-06	3.06e-05	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—INS—polycystic ovary syndrome	4.43e-06	3.04e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.22e-06	2.9e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.02e-06	2.76e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.99e-06	2.74e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—IL6—polycystic ovary syndrome	3.88e-06	2.67e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.88e-06	2.67e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.81e-06	2.62e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.64e-06	2.51e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.6e-06	2.48e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.56e-06	2.44e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.55e-06	2.44e-05	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.54e-06	2.43e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.25e-06	2.24e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.1e-06	2.13e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.94e-06	2.02e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.88e-06	1.98e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.84e-06	1.95e-05	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.82e-06	1.94e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.74e-06	1.88e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.22e-06	1.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.19e-06	1.51e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.18e-06	1.5e-05	CbGpPWpGaD
